Skip to content

Regenxbio RGNX Total debt

Total debt at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$198.51M-3.4%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$1.43B+138%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$22.31M-7.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$20.54M-13.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $71.07M.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's total debt?
Regenxbio (RGNX) reported total debt of $71.07M in Q1 2026.
How has Regenxbio's total debt changed year-over-year?
Regenxbio's total debt decreased by 11.0% year-over-year, from $79.85M to $71.07M.
What is the long-term trend for Regenxbio's total debt?
Over 5 years (2020 to 2025), Regenxbio's total debt has grown at a 0.2% compound annual growth rate (CAGR), from $72.65M to $73.5M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.